Clinical studies recruiting near Klagenfurt

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Austrian PBC Registry
Phase N/A · Klinikum Klagenfurt am Wörthersee · Medical University of Vienna · NCT07598669 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Klinikum Klagenfurt am Woerthersee · Amgen · NCT07037433 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Innere Medizin · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Klinikum Klagenfurt Am Wörthersee, Merz Investigational Site · Merz Therapeutics GmbH · NCT07018700 NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross-
NA · Unfallkrankenhaus Klagenfurt · AUVA · NCT04474106 LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · Local Institution - 0084 · Bristol-Myers Squibb · NCT05489705 Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosi
Phase 3 · Klinikum Klagenfurt Am Wörthersee · Takeda · NCT05677971 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Phase 3 · Klinikum Klagenfurt Am Wörthersee, Merz Investigational Site · Merz Therapeutics GmbH · NCT07018713 Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild
Phase 3 · KABEG - Klinikum Klagenfurt Am Wörthersee · Takeda · NCT06165341 A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocar
Phase N/A · KABEG Klinikum Klagenfurt am Wörthersee - Landeskrankenansta · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT05993234 EURO-STIM Registry
Phase N/A · Klinikum Klagenfurt, KABEG · Inspire Medical Systems, Inc. · NCT06971796 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Klinikum Klagenfurt Am Worthersee · Mirati Therapeutics Inc. · NCT04613596 Met Non Small Cell Cancer Registry (MOMENT)
Phase N/A · Klinikum Klagenfurt Am Woerthersee · EMD Serono Research & Development Institute, Inc. · NCT05376891 Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Phase N/A · 14 · Pierre Fabre Pharma GmbH · NCT04045691 Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin
Phase 2 · Klinikum Klagenfurt am Wörthersee · Salzburger Landeskliniken · NCT04204837 The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage Hepato
Phase 3 · Klinikum Klagenfurt am Wörthersee · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT04803994 Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast Cancer
Phase N/A · Centro di Riferimento Oncologico - Aviano · NCT06738459 The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients
Phase 3 · Klinikum am Wörthersee · Medical University of Graz · NCT03188796 CytOSorb TreatMent Of Critically Ill PatientS Registry
Phase N/A · Klinikum Klagenfurt am Wörthersee · CytoSorbents, Inc · NCT05146336 An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small
Phase N/A · Klinikum Klagenfurt · Regeneron Pharmaceuticals · NCT05363319 Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
Phase N/A · Klinikum Klagenfurt · Medical University Innsbruck · NCT06954311 A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-Wor
Phase N/A · Klinikum Klagenfurt am Worthersee · Janssen Research & Development, LLC · NCT07230691 DESTINY Breast Respond HER2-(Ultra)Low Europe
Phase N/A · Klinikum Klagenfurt am Wörthersee · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT05945732 Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Therapy-Resistant Myofascial Pain Syndrome
NA · Abteilung für Anästhesiologie und Intensivmedizin, Klinikum · Sobet AG · NCT05851326 Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI)
NA · Klinikum Klagenfurt am Wörthersee · Rede Optimus Hospitalar SA · NCT06898086 A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06318169 Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
NA · Klinikum Klagenfurt am Wörthersee · Charite University, Berlin, Germany · NCT05665608

Look up another city

Look up another condition